UK markets open in 5 hours 57 minutes
NIKKEI 225
38,606.39 -313.87 (-0.81%) HANG SENG
19,376.53 +302.82 (+1.59%) CRUDE OIL
79.29 +0.06 (+0.08%) GOLD FUTURES
2,382.30 -3.20 (-0.13%) DOW
39,869.38 -38.62 (-0.10%) Bitcoin GBP
51,675.77 -523.94 (-1.00%)
Esperion Therapeutics, Inc. (ESPR)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 435.76M |
| Enterprise value | 478.14M |
| Trailing P/E | N/A |
| Forward P/E | 10.00 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.31 |
| Price/book (mrq) | 74.89 |
| Enterprise value/revenue | 2.08 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 34.50% |
| S&P500 52-week change 3 | 26.44% |
| 52-week high 3 | 3.4000 |
| 52-week low 3 | 0.7000 |
| 50-day moving average 3 | 2.2774 |
| 200-day moving average 3 | 1.8299 |
Share statistics
| Avg vol (3-month) 3 | 7.18M |
| Avg vol (10-day) 3 | 10.81M |
| Shares outstanding 5 | 189.46M |
| Implied shares outstanding 6 | 189.46M |
| Float 8 | 184.16M |
| % held by insiders 1 | 0.45% |
| % held by institutions 1 | 65.93% |
| Shares short (30 Apr 2024) 4 | 19.87M |
| Short ratio (30 Apr 2024) 4 | 2.79 |
| Short % of float (30 Apr 2024) 4 | 10.60% |
| Short % of shares outstanding (30 Apr 2024) 4 | 10.58% |
| Shares short (prior month 28 Mar 2024) 4 | 19.92M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -37.65% |
| Operating margin (ttm) | 52.47% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 229.74M |
| Revenue per share (ttm) | 1.83 |
| Quarterly revenue growth (yoy) | 466.10% |
| Gross profit (ttm) | N/A |
| EBITDA | -34.56M |
| Net income avi to common (ttm) | -86.51M |
| Diluted EPS (ttm) | -0.9000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | -3.85 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.